The tissue response to foreign materials including biomaterials and medical devices is known as the foreign body response and is universally characterized by inflammatory cell recruitment and subsequent encapsulation of the foreign material by fibrotic tissue. 1 At the site of implantation an array of inflammatory mediators (and signaling molecules) including cytokines, growth factors, extracellular matrix proteins, and matrix-degrading enzymes create a dynamic microenvironment that mediates a defined sequence of events. 2 In the initial acute inflammatory phase, neutrophils are recruited to the surface of the implanted materials, followed by lymphocyte and mononuclear cell involvement and foreign body giant cell formation (chronic inflammation). If the foreign material cannot be removed, resolution of these inflammatory responses occurs when a fibrous capsule has formed around it. 3 Although the purpose of fibrous encapsulation is to isolate foreign material from the surrounding tissue, this fibrotic tissue, along with foreign body giant cells at the tissue/material interface, can significantly compromise the efficiency of medical devices or prostheses and frequently leads to device failure.
Our laboratory has observed a similar response to foreign material implanted in the peritoneal cavity. Within the first 3 to 5 days after implantation, the object is covered by rounded cells, many of which have a macrophage-like morphology and express the common leukocyte antigen Ly-5 (CD45). 4 After 2 to 3 weeks, a tissue capsule comprising multiple layers of myofibroblasts and extracellular matrix and covered by a continuous layer of mesothelial cells surrounds the object. 5 In contrast with the tissue surrounding foreign material at other anatomical sites, the tissue encapsulating free-floating foreign objects in the peritoneal cavity is avascular. On harvest, the tissue has been used as an autologous graft for replacement/repair of hollow smooth muscle organs including blood vessels, bladder, vas deferens, and uterus. [5] [6] [7] Over the ensuing 2 to 3 months, the grafted tissue undergoes further cell differentiation and tissue remodeling to assume the morphology and function of the host organ. 8 In addition to providing a sterile location to develop myofibroblast-rich tissue for engineering purposes, the peritoneal cavity is a convenient site to investigate the involvement of myeloid cells in the inflammatory response. The mononuclear phagocyte system encompasses bone marrow precursors, peripheral blood monocytes, tissue macrophages, and dendritic cells, all of which express the macrophage colony-stimulating factor receptor (csf1r). 9 -11 Macrophages also express F4/80 12, 13 and exhibit phenotypic and functional heterogeneity (reviewed in 14). Recently, blood monocytes have also been shown to exhibit heterogeneity in terms of expression of surface molecules such as Gr1 (Ly6C), chemokine receptors (CX3CR1), and migratory predisposition. [15] [16] [17] Understanding the cellular processes involved in the foreign body response is central to the development of tissue engineering strategies using the resultant myofibroblast-rich tissue. It is also the key to maintaining the integrity and function of biomedical implants such as orthopedic implants, dental or breast implants, artificial organs, vascular grafts, heart valves, renal dialyzers, and controlled drug delivery systems. Thus, the aims of the current study were to characterize the cells involved in the inflammatory response to foreign objects implanted in the peritoneal cavity and to determine whether monocyte/ macrophages are the source of peritoneum-derived tissue capsule myofibroblasts. We have previously demonstrated that myofibroblasts within the tissue capsule are of bone marrow (hematopoietic) origin using sex-mismatched bone marrow transplant experiments. 4 Others have demonstrated that labeled peripheral blood mononuclear cells, injected into the peritoneal cavity at the same time as foreign object implantation, contribute to tissue capsule formation. 18 However, it is not clear whether monocyte/macrophages are a cellular source of tissue capsule myofibroblasts. Thus, we investigated the hypothesis that in the peritoneal foreign body response, monocyte/macrophages can transdifferentiate to myofibroblasts.
For these investigations we used the transgenic MacGreen mouse in which a promotor region of the c-fms (csf1r) proto-oncogene directs myeloid-specific expression of the reporter gene, enhanced green fluorescent protein (EGFP). 19, 20 The c-fms gene encodes the receptor for the cytokine CSF-1, which is essential for macrophage survival, proliferation, and differentiation. Our results demonstrate that the inflammatory myeloid cells recruited into the peritoneal cavity exhibit differential (bimodal) expression of csf1r-EGFP; when used in conjunction with markers F4/80 and Ly6C, the csf1r-EGFP reporter provides a unique marker of monocyte/macrophage subsets and neutrophilic granulocytes. We also show that monocyte/macrophages within the tissue capsule are capable of differentiating to a mesenchymal phenotype, evidenced by co-expression of myeloid (EGFP) and myofibroblast (␣-smooth muscle [SM] actin) markers. These results provide evidence of the capacity for fully differentiated macrophages to transdifferentiate and suggest a greater potential for cellular plasticity than recognized previously.
Materials and Methods

Mice
Male and female c-fms-EGFP ("MacGreen") mice (in which a 7.2-kb promoter element of the c-fms gene, including the key enhancer, fms intronic regulatory element, directs specific expression of EGFP in macrophage, trophoblast, and granulocyte lineages) 19, 20 and wild-type (C57BL/6) control mice were purchased from the Transgenic Animal Service of Queensland and the University of Queensland Biological Resources, University of Queensland (St. Lucia, QLD, Australia). Mice were used at the age of 8 to 16 weeks in all experiments and maintained in our on-site animal facility according to institutional guidelines. All procedures were approved by the University of Queensland Animal Ethics Committee Guidelines and conform to the Animal Care and Protection Act Qld (2002) 
Foreign Objects
In this study, sterile cubes of boiled chicken egg white (approximately 0.125 cm 3 ) were used as foreign objects. Egg white is composed predominantly of ovalbumin, an avian protein not found in mammals. Because it is acellular and almost 100% protein, it can be easily removed during RNA isolation procedures. It can also be easily fixed and sectioned for histological analysis of the encapsulating fibrotic tissue.
Surgical Procedure
Mice were anesthetized by inhalation of isoflurane (2% in oxygen). Using sterile techniques, a 1-cm midline abdominal incision was made, and the foreign objects (4 cubes of boiled egg white) were inserted into the peritoneal cavity along with 1 ml of sterile 0.9% sodium chloride (Baxter Healthcare, Sydney, Australia). The peritoneal wall was closed with 4-0 Vicryl (Ethicon, Johnson & Johnson, Somerville, NJ), and the skin was sutured with 5-0 Sofsilk (Syneture, Mansfield, MA). In control animals surgery was performed as above, but implantation of the cubes of boiled egg white was omitted.
Macrophage Depletion
Macrophage depletion was achieved using the "liposome-mediated macrophage suicide technique." 21 Clodronate-encapsulated liposomes are taken up by phagocytosis; clodronate is then released into the cell by disruption of the phospholipid bilayers of the liposomes and induces apoptosis of the macrophage. 22 To eliminate macrophages from the peritoneal cavity, mice received i.p. injections of 0.1 ml of liposome-encapsulated clodronate 2 days before implantation of cubes of boiled egg white and then 2 and 4 days after the surgical procedure. This ensured depletion of both resident peritoneal macrophages and recently recruited macrophages either from the omentum or circulating blood monocytes. 23 Clodronate was a gift from Roche (Mannheim, Germany) and incorporated into liposomes as previously described. 21 
Animal Sacrifice and Isolation of Cells
At various time points after implantation (days 2, 4, 7, 14, 21, and 28), mice were euthanized by carbon dioxide inhalation. The peritoneal cavity was lavaged by introduction of 10 ml of ice-cold (4°C) calcium-and magnesiumfree Dulbecco's PBS (Invitrogen, Eugene, OR). Peritoneal exudate cells were collected into 15-ml centrifuge tubes by puncturing the abdomen with an 18-gauge needle (Becton Dickinson, San Jose, CA). Cubes of boiled egg white and encapsulating tissue were removed and placed in PBS (Invitrogen) for further processing; only those that were free-floating and not attached to the serosal surface were harvested for further analysis.
Collagenase Digestion of Tissue Capsule Cells
Single cell suspensions of tissue capsules were obtained by enzymatic digestion in collagenase (3.5 mg/ml in RPMI 1640, Worthington Biochemicals, Freehold, NJ) at 37°C for 1 hour. Cell suspensions were used for flow cytometric analysis.
Flow Cytometry
To enumerate recruitment of cells into the peritoneal cavity at various time points, absolute cell counts were determined using Flow-Count Fluorospheres (Beckman Coulter, Fullerton, CA) according to the manufacturer's guidelines and analyzed on an LSRII cytometer using Diva software (version 6.1.1, Becton Dickinson). For cell surface phenotyping, single-cell suspensions of peritoneal exudates or tissue capsules (10 6 cells/tube) were washed once in calcium-and magnesium-free PBS containing 0.1% bovine serum albumin and 0.1% sodium azide (PBA, Sigma-Aldrich, St. Louis, MO), pelleted, and incubated with 5% rat serum (Sigma-Aldrich) in PBA for 30 minutes at 4°C. After washing, cells were incubated with rat anti-mouse CD16/CD32 (2.4G2, Mouse BD Fc Block) for 15 minutes before staining with R-phycoerythrin-conjugated anti-F4/80 (clone A3-1, Serotec, Raleigh, NC), anti-CD45 (clone 30-F11), anti-Cd11b (clone M1/70), anti-Gr1 (Ly6G/C, clone Rb6-8C5), or anti-Ly6G (clone 1A8) (all obtained from BD Pharmingen, San Diego, CA) or with Alexa Fluor 647-conjugated Ly6C (clone ER-MP20, Serotec) for 30 minutes at 4°C, followed by washing in PBA.
For intracellular staining, cells were fixed in 4% paraformaldehyde (Electron Microscopy Sciences, Hatfield, PA) for 10 minutes and permeabilized with 0.1% saponin (Sigma-Aldrich) for 5 minutes, followed by incubation in PBS containing 5% donkey serum (Sigma-Aldrich) for 30 minutes at room temperature. Cells were then incubated with rabbit monoclonal antibody to ␣-SM actin (Epitomics, Burlingame, CA) for 30 minutes at room temperature, followed by Cy5-conjugated donkey anti-rabbit IgG (Jackson ImmunoResearch Laboratories, West Grove, PA). Immunostaining with the relevant isotype controls was also performed to control for nonspecific binding. Cells were analyzed on an LSRII cytometer using Diva software.
For cell sorting, isolated tissue capsule cells were separated on the basis of size/granularity (forward/side scatter) and fluorescence intensity of EGFP, using FACSVantage SE Diva and Diva software (version 5.2), according to the manufacturer's standard configuration.
Morphological Analysis with DIFF-Quik
For differential staining of fluorescence-activated cell sorting (FACS)-separated tissue capsule cells, cytocentrifuged samples were stained with a DIFF-Quik stain set (Lab Aids, Narrabeen, NSW, Australia) according to the manufacturer's instructions and mounted in mount-quick (Daido Sangyo Co., Shinada, Japan). DIFF-Quik is a Romanowsky-type stain that provides rapid histological evaluation of peripheral blood and bone marrow smears. With this technique, monocytes and granulocytes are easily identified by their distinct nuclear and cytoplasmic staining. 24 
Embedding and Tissue Sectioning
Tissue was OCT-embedded according to methods described previously. 19 Frozen sections (10-m-thick) were cut using a Leica 3050 cryostat (Leica Instrument, Wetzlar, Germany) and collected directly onto SuperFrost Plus glass slides (Menzel-Glaser, Braunschweig, Germany). Slides were air-dried for 1 hour and then were processed for immunofluorescence analysis.
Immunohistochemistry
Nonspecific binding was blocked by incubation of tissue sections in blocking buffer (5% goat serum; SigmaAldrich) and 1% bovine serum albumin (Sigma-Aldrich) in PBS for 1 hour at room temperature. Sections were then incubated with rabbit ␣-SM actin monoclonal antibody overnight at 4°C. Secondary staining was performed using an Alexa Fluor 594-conjugated goat anti-rabbit IgG (Invitrogen) with incubation for 1 hour at room tempera-ture. Sections were counterstained with the nuclear dye Hoechst 33342 (Invitrogen) and mounted in ProLong Gold antifade reagent (Invitrogen).
Morphological Analysis of Tissue Capsules
To visualize EGFP expression by cells within tissue capsules, frozen sections were counterstained with Hoechst 33342 and mounted in ProLong Gold antifade reagent.
Statistical Analysis
Data are presented as means Ϯ SD. PRISM software (GraphPad Software, Inc., San Diego, CA) was used to analyze differences between samples by one-way analysis of variance with Dunnett's multiple comparison test. For all experiments values of P Ͻ 0.01 were considered significant.
Results
Cell Recruitment to the Peritoneal Cavity After Sterile Foreign Object Implantation
The implantation of foreign objects (sterile cubes of boiled egg white) in the peritoneal cavity of MacGreen and C57BL/6 (control) mice resulted in a significant increase in the number of cells within the cavity at all time points examined (days 2, 4, 7, 14, 21, and 28) compared with that in the normal ("unstimulated") peritoneal cavity (P Ͻ 0.01) ( Figure 1 ). Cell numbers were maximal at day 7, with 51.6 Ϯ 8.8 ϫ 10 6 cells within the cavity at this time. The persistent inflammatory cell infiltrate occurred in response to the implanted foreign objects, because surgery alone elicited a short-lived inflammatory response, which had resolved by day 7; at this time point the peritoneal cavity of "surgery alone" controls contained 10 Ϯ 2.7 ϫ 10 6 cells, not significantly different from the number in the unstimulated peritoneal cavity (P Ͼ 0.05).
Myeloid Cell Recruitment to the Peritoneal Cavity After Sterile Foreign Object Implantation
FACS analysis showed that within the unstimulated peritoneal cavity of MacGreen mice, there were two distinct populations of cells: EGFP-negative (EGFP Ϫ ) (57.6 Ϯ 5.6%) and EGFP-positive (EGFP ϩ ) (42.4 Ϯ 5.6%) ( Figure  2A ). The EGFP ϩ population was composed almost exclusively of cells expressing high levels of EGFP (EGFP hi ). After implantation of foreign objects the proportion of EGFP ϩ cells within the peritoneal exudate increased markedly to 74.7 Ϯ 8.1% of total cells at day 2 after implantation ( Figure 2B ). The EGFP ϩ population at this time point exhibited marked heterogeneity in EGFP expression levels and could be divided into two subpopulations, the EGFP hi population seen before implantation and a second population of low EGFP-expressing cells (EGFP lo ). The proportion of the EGFP lo subset increased with time after implantation to a maximum at day 7 ( Figure  2C ), comprising 52.3 Ϯ 7.4% of total EGFP ϩ cells, coincident with maximal total cell numbers (shown in Figure  1) ; after this time, the proportion of EGFP lo cells decreased. At day 28 after implantation, EGFP ϩ cells still contributed 63.7 Ϯ 4.8% of total cells within the peritoneal Cell recruitment to the peritoneal cavity after foreign object implantation. Histogram shows total cell numbers (mean Ϯ SD) in the peritoneal cavity before (day 0) and at various times after implantation of cubes of boiled egg white. Surgery alone (no implantation) elicited a transient inflammatory response, which was ameliorated by day 7. *P Ͻ 0.01 compared with day 0 (n ϭ 9 mice for each time point from three independent experiments). , and EGFP hi cells in the peritoneal cavity before and after implantation. The EGFP lo subset was observed from day 2 onward. Results are expressed as the mean % of total cells (n ϭ 9 mice for each time point from three independent experiments).
exudate, the majority of which were of the EGFP hi subset ( Figure 2D ). The EGFP Ϫ subset was also observed at all time points after implantation, with proportions remaining relatively constant throughout, from 25.3 Ϯ 8.1% of total cells at day 2 to 36.4 Ϯ 6.8% at day 28 ( Figure 2E ).
Characterization of the Peritoneal Inflammatory Cell Infiltrate
To characterize the cells involved in the inflammatory response to foreign objects implanted in the peritoneal cavity, peritoneal exudate cells were analyzed before implantation and 2, 4, 7, 14, and 28 days after implantation by flow cytometry. At all time points examined, Ͼ95% of total cells (both EGFP Ϫ and EGFP ϩ ) were leukocytes, identified by expression of CD45 ( Figure 3A) . The involvement of myeloid cells was then investigated using the markers CD11b and F4/80. Although CD11b is expressed by a number of cell types including monocyte/ macrophages, granulocytes, and lymphocytes, 25, 26 F4/80 is considered the most specific macrophage marker. 12, 13 Consistent with their identity as resident peritoneal macrophages, the majority of EGFP ϩ cells within the unstimulated peritoneal cavity stained for both CD11b (myeloid cells) ( Figure 3B ) and F4/80 (macrophages) ( Figure 3C ). The EGFP Ϫ subset never expressed F4/80, whereas a small proportion of these cells did express CD11b and were most likely lymphocytes.
The myeloid differentiation antigen Gr1 (Ly6C/G) is expressed on granulocytes (neutrophils and eosinophils) and monocytes and has recently been used to define murine blood monocyte subsets. 15 To gain further insight into the inflammatory cells recruited into the peritoneal cavity after foreign object implantation, we examined whether short-lived Gr1 (Ly6C/G) ϩ blood monocyte subsets described by Geissmann et al 15 were recruited to the peritoneal cavity after foreign object implantation and whether expression was restricted to either the EGFP hi or EGFP lo subset. Two different monoclonal antibodies were used in this study: clone RB6-8C5 that recognizes both Ly6C and Ly6G, 27 and ER-MP20, which recognizes only the Ly6C antigen. As shown in Figure 3D , Gr1 ϩ cells were not detected in the unstimulated peritoneal cavity, but a small proportion (10.3 Ϯ 3.4% of total cells) of both the EGFP Ϫ and EGFP ϩ fractions was shown to be Ly6C ϩ ( Figure 3E ). At 2 days after implantation of foreign objects, an influx of EGFP ϩ cells, which stained positive with either Ly6C or Gr1, was observed. Figure 3G ) were identified. Surprisingly, at this time point the majority of EGFP ϩ cells in the inflamed peritoneal cavity expressed detectable F4/80, but levels were higher in the EGFP hi subset ( Figure 3H) . A proportion of the EGFP hi subset did not express F4/80, and these most likely represent granulocytes newly recruited to the peritoneal cavity. Further characterization of the different subsets was achieved by costaining with F4/80 and Ly6C ( Figure 3I The cell populations in the peritoneal cavity changed rapidly. By day 4, an additional Ly6C ϩ subset was identified, characterized by intermediate expression of EGFP, very high Ly6C expression ( Figure 3J) , and low orthogonal (side) scatter (indicating mononuclearity) ( Figure 3K ). These cells would be considered the classic inflammatory monocyte, analogous to those attracted by stimuli such as thioglycollate broth. Concomitant with up-regulated expression of F4/80 at day 7 ( Figure 3L ), Ly6C ( Figure 3M ) and Gr1 ( Figure 3N ) were down-regulated on all subsets except a small population of EGFP lo cells. At this time Ͼ95% of EGFP ϩ cells expressed F4/80, providing evidence for a continuous maturation pathway of recruited monocytes and possibly granulocytes to macrophages. The inflammatory response had resolved by day 14, evidenced by the absence of (newly recruited) Ly6C ϩ cells in the peritoneal cavity ( Figure 3O ). In addition, the Ly6C expression observed on the EGFP lo subset at day 7 was completely down-regulated. At this time all EGFP ϩ cells expressed F4/80 ( Figure 3P ). The FACS profiles for day 28 peritoneal cells (not shown) closely resembled those for day 14.
Because the Gr1 (Ly6C/G) antigen is commonly used to mark murine monocyte subsets and the current study identified two subsets of Gr1 ϩ cells in the inflammatory infiltrate, we used this antibody to sort the cells and then confirm their identity based on morphology ( Figure 4A ). Diff-QUIK staining of the EGFP lo Gr1 lo subset revealed that it was composed entirely of neutrophils, characterized by their pale-pink cytoplasmic staining ( Figure 4B ). The EGFP hi Gr1 hi subset was composed almost exclusively of polymorphonuclear-like ring cells ( Figure 4C) , with a small number of ring-shaped mononuclear cells, similar to those described by Biermann et al, 28 also detected. These cells may represent the Gr1 ϩ subset of inflammatory monocytes described by Geissmann et al. 15 To investigate the observation that a proportion of the EGFP lo subset of peritoneal exudate cells expressed granulocyte-specific markers and exhibited morphological features of polymorphonuclear cells, but also expressed the macrophage-specific marker F4/80, peritoneal lavage cells were FACS-sorted based on EGFP and F4/80 expression ( Figure 4D ). Morphological characterization of DIFF-Quik-stained cells confirmed that by day 2 inflammatory neutrophils express detectable F4/80 antigen, albeit at lower levels than mature macrophages. The EGFP lo F4/80 lo subset contained neutrophils and monocytes ( Figure 4E) , whereas macrophages at different developmental stages comprised the EGFP hi F4/80 hi subset ( Figure 4F ). This result is in agreement with our previous demonstration that inflammatory neutrophils obtained 24 hours after peritoneal injection of thioglycollate broth can acquire F4/80 and other macrophage-specific gene expression in vitro in response to CSF-1. 20 The unequivocal expression of F4/80 by neutrophils lends further support to the possibility that neutrophils can transdifferentiate to macrophages.
EGFP-Positive Cell Involvement in the Developing Tissue Capsule
Confocal microscopy of tissue capsule sections showed that at day 2 after implantation, the surfaces of implanted cubes of boiled egg white collected from MacGreen mice were covered by one to two layers of cells, most of which had a rounded appearance and expressed EGFP ( Figure  5A ). By day 14, the object was completely encapsulated by tissue, which was several cell layers thick, with the majority of cells still expressing EGFP ( Figure 5B ). At this time, EGFP ϩ cells with both rounded and spindle-shaped morphologies were observed; rounded cells expressed high levels of EGFP aggregated in the innermost layers of the capsule, whereas the spindle-shaped cells were located toward the periphery. By day 28, the capsule did not seem to have increased in thickness, and EGFP ϩ cells were still major contributors. Many spindleshaped cells were evident within the inner layers of the capsule, some of which still expressed EGFP ( Figure  5C ). Rounded cells expressing high levels of EGFP ϩ were frequently observed on the surface of the tissue capsule, suggesting that monocyte/macrophages were still contributing to tissue capsule formation. Vascularization of the tissue capsule was never observed. EGFP expression was never detected in tissue capsules obtained from C57BL/6 control mice ( Figure 5D ). Furthermore, tissue capsule development was identical in wildtype and MacGreen mice, indicating that the csf1r-EGFP transgene had no effect on the cellular response to the implanted foreign objects.
FACS analysis of cells isolated from tissue capsules showed that the proportion of EGFP ϩ cells in the tissue capsule increased from 27.6 Ϯ 7.4% of total cells at day 2 to 68.1 Ϯ 6.9% at day 7 and remained elevated through to day 28 when they constituted 61.9 Ϯ 10.6% of total cells ( Figure 5E ). EGFP Ϫ cells also contributed to tissue capsule development, and morphological analysis revealed that this subset comprised mainly mast cells and lymphocytes (data not shown). As observed for postimplantation peritoneal exudate cells, tissue capsule cells showed heterogeneity in EGFP expression levels, although the proportions of EGFP lo and EGFP hi cells varied and the distinctions between the two subsets was not clearly defined at the later stages of capsule development. At day 2, the majority of EGFP ϩ cells were of the EGFP hi phenotype with the EGFP lo subset comprising 9.7 Ϯ 1.4% of total cells ( Figure 5F ). The distinction between the two subsets became clearly evident at day 7 with the EGFP lo and EGFP hi populations comprising 24 Ϯ 6.8 and 44 Ϯ 5.7% of total cells, respectively ( Figure 5G ). From this time on the two subsets appeared to merge, with increasing EGFP expression possibly indicating differentiation/maturation of recruited monocytes and granulocytes (EGFP lo ) to macrophages (EGFP hi ) ( Figure 5H ). By day 28, the majority of cells were of the EGFP hi phenotype and the two subsets could not be clearly separated ( Figure 5I ).
Characterization of Tissue Capsule Cells
To further characterize the cells involved in tissue capsule formation, single-cell suspensions were prepared from tissue capsules at days 2, 4, 7, 14, and 28 after implantation and expression of myeloid markers was analyzed by FACS. For all markers, tissue capsule cells displayed a pattern of expression similar to that observed for peritoneal exudate cells. At all time points, the majority of tissue capsule cells expressed CD45, with the exception of a small subset of EGFP Ϫ cells ( Figure 6A ). The majority of EGFP ϩ cells also expressed the macrophage marker F4/80 ( Figure 6B ). As described for peritoneal exudate cells, monocyte-to-macrophage maturation was indicated by up-regulation of EGFP and F4/80 over time. At day 28, F4/80 ϩ macrophages still contributed 50 Ϯ 6.7% of total cells ( Figure 6C ), confirming confocal microscope images showing EGFP ϩ cells with macrophage-like morphology within the tissue capsule at this time point ( Figure 5C ).
Immunostaining with Gr1 and Ly6C antibodies identified an influx of Ly6C ϩ ( Figure 6D ) and Gr1 ϩ ( Figure 6E ) cells during early tissue capsule development, with maximal numbers at day 4. By day 7, there was an increase in the proportion of EGFP lo Ly6C ϩ cells, but as observed for peritoneal exudate cells the down-regulation of Ly6C expression by the EGFP hi subset had commenced (not shown). Ly6C (and Gr1) expression was down-regulated on all EGFP ϩ subsets by day 14 ( Figure 6F ), and no further recruitment of Ly6C ϩ cells occurred after this time. Morphological analysis of FACS-sorted EGFP ϩ sub- sets from the day 28 tissue capsule identified monocyte/ macrophages and neutrophils in the EGFP lo subset (Figure 6G) and macrophages, multinucleated giant cells, and other large cells, most likely myofibroblasts, within the EGFP hi fraction ( Figure 6H ).
Macrophages Are Essential for Tissue Capsule Development
The abundance of macrophages within the tissue capsule at all time points led us to investigate the importance of these cells in capsule development. Depletion of both peritoneal macrophages and recently recruited blood monocytes with liposome-encapsulated clodronate was confirmed by FACS analysis of peritoneal lavage cells from clodronate-treated mice, which showed a marked reduction in total EGFP ϩ cells compared with PBS liposomes or no-injection controls (data not shown). FACS analysis of tissue capsule cells at days 7 ( Figure 7A ) and 14 ( Figure 7B ) demonstrated a significant reduction in total EGFP ϩ cells. At day 7, clodronate-encapsulated liposomes caused 35.8 and 76.8% reductions in the proportion of EGFP lo and EGFP hi cells, respectively. The effect was more pronounced at day 14, with almost complete ablation of both EGFP ϩ subsets: a 73.3% reduction in the EGFP lo subset and a 97.9% reduction in the EGFP hi subset. PBS liposome control injections ( Figure 7C ) did not cause a significant change in the EGFP expression profile of tissue capsules from MacGreen mice compared with the no-injection controls ( Figure 7D ).
Histological analysis of tissue capsule sections showed a marked reduction in capsule development in clodronate-treated mice; at both days 7 and 14, the capsules consisted of only a monolayer of elongated mesothelial-like cells ( Figure 7E ). Conversely, in animals that received empty (PBS) liposomes, tissue capsule development resembled that in untreated mice. As shown in Figure 7F , the day 14 capsules from PBS liposometreated mice comprised multiple layers of rounded and spindle-shaped cells overlaid by a single layer of mesothelial-like cells. Taken together, these findings confirm the necessity for macrophages in tissue capsule development.
Macrophage Transdifferentiation into Tissue Capsule Myofibroblasts
Given the prevalence of macrophages within the tissue capsule through to day 28, along with previous research showing the hematopoietic origin of capsular myofibroblasts, 4 we sought to determine whether cells of myeloid origin (ie, monocyte/macrophages expressing EGFP) within the tissue capsule can transdifferentiate into ␣-SM actin-expressing myofibroblasts. We reasoned that such cells would retain the stable EGFP protein even if transcription of macrophage-specific genes was extinguished. Flow cytometric analysis of cells isolated from tissue capsules showed that at day 14, 12.7 Ϯ 0.5% of total cells expressed the myofibroblast marker ␣-SM actin and nearly 85% of these co-expressed EGFP. At day 21, 23 Ϯ 4.8% of cells expressed ␣-SM actin, and at day 28, 63 Ϯ 14.5% of total cells expressed ␣-SM actin with Ͼ80% of these cells co-expressing EGFP (Figures 8, A  and B) .
The presence of cells within the tissue capsule that co-express EGFP and ␣-SM actin was confirmed by immunohistochemical analysis. Within the day 14 tissue capsule, the majority of cells co-expressing EGFP and ␣-SM actin exhibited the rounded morphology of macrophages, with a small proportion exhibiting an elongated morphology (Figures 8, C and D) . By day 28, an increased proportion of cells co-expressing both markers was observed, and the majority of these exhibited a spindle-shaped morphology (Figure 8, E and F) . These results support the hypothesis that macrophages within the capsule transdifferentiate into myofibroblasts.
Discussion
The peritoneal foreign body response has been used by our laboratory to produce tissue suitable for replacement/ repair of damaged smooth muscle organs. This response resembles that described previously for experimental models of induced inflammation and the response to biomaterials in which the physical and chemical properties of the material modulate the precise cellular events. 3, 29 The present study shows that the cellular response to boiled egg white is similar to that previously reported by our laboratory and others for a variety of foreign materials implanted in the peritoneal cavity, including boiled blood clot, 30 silastic tubing, 5, 18 poly(lactic acid) scaffolds, 31 and acellular photo-oxidized bovine pericardium patches. 32 Given that the foreign object remains free-floating within the peritoneal cavity, our experimental model also provides a means by which to study the cells involved in the sterile inflammatory response without contamination by surrounding tissue. The present study confirms the central role of myeloid cells in the production of tissue that encapsulates foreign objects in the peritoneal cavity and further provides definitive evidence that monocyte/macrophages are able to transdifferentiate in vivo to a myofibroblastic phenotype. Although the primary focus of this study was to investigate the involvement of myeloid cells in the peritoneal foreign body response, the presence of nonmyeloid (EGFP Ϫ ) cells, including lymphocytes, was also observed in tissue capsule development. This finding is in agreement with results of other studies demonstrating the involvement of lymphocytes in the tissue response to foreign materials. [33] [34] [35] We demonstrate that implantation of sterile foreign objects in the peritoneal cavity initiates an inflammatory response in which EGFP ϩ Gr1 ϩ (Ly6C ϩ ) monocytes and granulocytes are rapidly recruited to the peritoneal cavity and encapsulate the foreign object. Morphological analysis shows that the EGFP ϩ Gr1 ϩ (Ly6C ϩ ) cells, which enter the peritoneal cavity and encapsulate the implanted object in the early phase (at day 2), are primarily granulocytes, with monocytes representing only a minor subset. However, many of these cells also express the macrophage-specific F4/80 antigen, suggesting that monocytes and granulocytes may not represent two different lineages but rather different stages of a single lineage. As the inflammatory response progresses, expression of Ly6C by monocytes and granulocytes is down-regulated, with concomitant up-regulation of F4/80 and the csf1r-EGFP transgene such that F4/80 ϩ macrophages become the predominant cell type within the peritoneal cavity and the tissue capsule. Thus, we propose that at least some of the so-called "short-lived" Gr1 ϩ subset may not undergo apoptosis to be replaced by a second wave of newly recruited monocytes but instead transdifferentiate to F4/80 lo Gr1 Ϫ monocytes. Although this hypothesis needs further investigation, it is supported by previous research showing that the csf1r-EGFP reporter is also expressed by Gr1 ϩ granulocytes in MacGreen mice and that inflammatory neutrophils can express macrophage-specific genes. 20 In response to an array of cytokines including granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-␣, and CSF-1, human neutrophils have also been shown to differentiate into macrophages in vitro. 36 The persistence of macrophages within the tissue capsule surrounding the foreign object is a key feature of the inflammatory response to implanted materials. 29 In our experimental model, the EGFP ϩ subsets of the day 28 tissue capsule include macrophages, multinucleated giant cells, and a small number of neutrophils, although many cells with spindle-shaped myofibroblastic morphology are also present. The importance of macrophages in capsule development was confirmed by clodronate-encapsulated liposome-mediated depletion experiments, which almost completely abrogated tissue capsule development. In this study, we showed that intraperitoneal injections of clodronate-encapsulated liposomes eliminated both resident peritoneal macrophages and recently recruited monocytes. Not surprisingly, this treatment also almost completely removed the EGFP lo subset, which is composed of predominantly polymorphonuclear neutrophils that also have phagocytic capabilities. It is important to note that this route of administration has been shown to deplete macrophages in spleen, lymph nodes, and liver. 23 These results indicate that macrophages are essential for development of the multilayered tissue capsule suitable for replacement/repair of smooth muscle organs. 5 As a central finding, we show that from day 14 onward the developing tissue capsule contains a subset of EGFP ϩ cells that co-express ␣-SM actin, increasing with time to comprise Ͼ80% of total ␣-SM actin ϩ cells within the capsule at day 28. In addition, with progressive development of the tissue capsule the morphology of EGFP ϩ ␣-SM actin ϩ cells changed from a rounded macrophage-like appearance to a more spindle-shaped myofibroblastic phenotype. Taken together, these results provide definitive evidence that monocyte/macrophages are capable of transdifferentiating to myofibroblasts. The retention of EGFP expression by these "transdifferentiated" myofibroblasts is most likely due to the relatively long half-life of the EGFP protein. These results confirm earlier electron microscopic studies, which reported the presence of cells intermediate in morphology between macrophage and fibroblast/myofibroblast within the tissue capsule 30 and provide evidence that the hematopoietic progenitor of the myofibroblast is the macrophage. 4 Macrophages have many trophic roles in development and are essential for effective tissue regeneration. 37 Although the role of macrophages was previously attributed to the paracrine production of cytokine/growth factors and extracellular matrix proteins to recruit and support other cell types, 2,38 the present study provides evidence for a more direct role in this process by way of their capacity to transdifferentiate into myofibroblasts. The ability of macrophages to transdifferentiate to fibroblasts has been documented previously, 39, 40 with cultured peritoneal macrophages from Schistosoma mansoni chronically infected mice exhibiting fibroblast-like characteristics and co-expressing the fibroblast (procollagen) and macrophage (mac-1/mac-2) markers. Thioglycollatestimulated peritoneum-derived macrophages have also been shown to transdifferentiate into smooth muscle-like cells/myofibroblasts in response to transforming growth factor-␤, evidenced by up-regulation of smooth muscle/ myofibroblast markers such as calponin and ␣-SM actin and concomitant down-regulation of the macrophage marker CD11b. 41 The bidirectionality of macrophagemyofibroblast-smooth muscle cell transdifferentiation of these two cell types is suggested by the demonstration that smooth muscle cells adopt a macrophage-like phenotype after in vitro cholesterol loading. 42 The possibility that peritoneal macrophages participating in the peritoneal foreign body response have the capacity to transdifferentiate was first proposed in 1972 by Kouri and Ancheta, 43 who demonstrated the presence of cells with intermediate morphologies between macrophages and fibroblasts within tissue capsules that formed around Epon lamina implants. Likewise our laboratory identified macrophage-fibroblast intermediary cells in the tissue capsule around free-floating intraperitoneal blood clots, lending further support to the transdifferentiation capacity of peritoneal macrophages. 30, 44 More recently, Jabs et al 18 showed that PKH-26-labeled peripheral blood mononuclear cells injected into recipient animals before foreign object implantation incorporated into the tissue capsule and that from day 14 onward, a proportion of ␣-SM actin-expressing spindle-shaped cells co-expressed macrophage markers (ED1/ED2). The present study corroborates and extends these in vivo studies and demonstrates that inflammatory tissue macrophages are capable of acquiring the characteristics of myofibroblasts, including the expression of ␣-SM actin.
These findings indicate a greater cellular plasticity for myeloid cells than previously envisaged and suggest that within its lifetime, a single cell has the capacity to adopt a range of phenotypes and functions according to physiological needs. The results presented here suggest a continuum from monocyte (or granulocyte) through macrophage to myofibroblast. Indeed our previous studies indicate that when subjected to the appropriate environmental cues, such as hemodynamic factors and active stretch, 45 these cells have the capacity to differentiate even further. For example, when tubes of this myofibroblast-rich tissue (formed around a tubular molding im-planted into the peritoneal cavity for 2 to 3 weeks) are grafted into an autologous artery to replace excised segments, the tissue develops the characteristics of mature vascular smooth muscle and constituent cells express smooth muscle differentiation markers including smoothelin and the smooth muscle myosin isoform SM-2. 6, 7 We present here a thorough cellular characterization of the myeloid cells involved in the inflammatory response to implanted foreign material. Specifically, we show that after the initial recruitment of monocytes and granulocytes, macrophages become the predominant cell within both the peritoneal cavity and the tissue capsule. Furthermore, the results provide evidence to suggest that in addition to the established monocyte-to-macrophage differentiation, there is a continuous pathway of maturation from granulocyte through monocyte/macrophage and further to myofibroblast. These results question the traditional notion of distinct terminally differentiated cell types with specific functions. We propose that, at least for some cell lineages, cellular identity is more fluid than recognized previously and that cells may adapt their phenotype and function according to local environmental cues. Understanding the mechanisms regulating this process may be the key to advances in tissue engineering.
